First-Ever Cannabis Periodic Table of Molecules™ Created by Acannability™
Acannability™ created the first-ever Cannabis Periodic Table of Molecules™ chart which reflects the original periodic table of elements.
In a recent press release (1), Acannability™ released the first-ever Cannabis Periodic Table of Molecules™ chart (2). The company is based in Chicago, Illinois and disclosed in their press release that they are “a member-driven, direct to consumer cooperative for the cannabis industry,” (1). In the company’s cannabis periodic table, it was meant to visually reflect the design of the periodic elements. It lists 51 cannabis molecules and precursor acids which have been categorized into four areas (1).
Acannability™’s Cannabis Periodic Table of Molecules™ chart was created via the review of over 400 molecules and the benefits associated with them that were detailed in published journals (1). The company hopes that this chart will help with education efforts in healthcare and also those interested in learning more about the industry. Scientific Advisor Joseph Friedman, RPh, MBA, a medical cannabis pharmacist and pharmacology expert, led the chart’s evolution (1).
"The Acannability™ table was developed to empower consumers with scientific facts of the plants ingredients," Friedman explained (1). "By utilizing this table, it is our hope that consumers will be able to make more informed purchasing decisions based on their needs and the products specific elements."
Shown in the Cannabis Periodic Table of Molecules™ there are four categories: cannabinoids, flavonoids, terpenes, cannabinoids, and 6 precursor acids which are displayed underneath the other molecule sections (1,2). The chart contains a total of 51 boxes with the molecules being listed from left to right and go by increasing atomic weight (1).
Acannability™ wishes that their periodic table will be utilized to inspire conversation regarding the plant’s benefits, as well as, education, selection of products, and industry trends (1). The goal is to encourage cannabis consumers to use their education and knowledge to help them figure out what cannabis products would be best for them to purchase (1).
Acannability™’s Cannabis Periodic Table of Molecules™ chart is accessible to Acannability members and is also offered at no cost to the cannabis community via a copyright license acknowlesgement (1). For a printable version of the chart, please can visit their website: https://acannability.com (3).
References
- Acannability. AcannabilityTM Launches First Periodic Table of Cannabis Molecules Aimed at Mutual Education Between Consumer and Industry Leaders https://www.prnewswire.com/news-releases/acannability-launches-first-periodic-table-of-cannabis-molecules-aimed-at-mutual-education-between-consumer-and-industry-leaders-301998657.html#:~:text=%22The%20AcannabilityTM%20table%20was,and%20the%20products%20specific%20elements.%22 (accessed Nov 28, 2023).
- Acannability. Cannabis Periodic Table of Molecules https://acannability.com/periodictable/ (accessed Nov 28, 2023).
- Acannability. https://acannability.com/ (accessed Nov 28, 2023).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Empowering Women in Cannabis: Susan Audino, PhD, on Inclusivity, Integrity, and Industry Challenges
December 11th 2024Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
